Parallel Advisors, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2022$00
-100.0%
0.00%
Q3 2022$0170.0%0.00%
Q2 2022$0170.0%0.00%
Q1 2022$0
-100.0%
17
-77.3%
0.00%
Q4 2021$3,000
+200.0%
75
+167.9%
0.00%
Q3 2021$1,0000.0%28
+40.0%
0.00%
Q2 2021$1,0000.0%200.0%0.00%
Q1 2021$1,000200.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders